Cite
HARVARD Citation
Mease, P. et al. (2021). Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis: 2-year (end-of-study) results from the FUTURE 5 study. RMD open. 7 (2), p. . [Online].